Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy

Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods

(2014) J Hobart et al.   HEALTH TECHNOLOGY ASSESSMENT

Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness

(2014) T. H. P. Draak et al.   NEUROLOGY

196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8–10 February 2013, Naarden, The Netherlands

(2013) Els K. Vanhoutte et al.   NEUROMUSCULAR DISORDERS

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

The use of raw scores from ordinal scales: Time to end malpractice?

(2012) G Grimby et al.   JOURNAL OF REHABILITATION MEDICINE

The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers

(2012) Laura S. Gilchrist et al.   SUPPORTIVE CARE IN CANCER

Modifying the Medical Research Council grading system through Rasch analyses

(2011) Els Karla Vanhoutte et al.   BRAIN

Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease

(2011) Sinéad M. Murphy et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ)

(2010) Mieke C.E. Hermans et al.   NEUROMUSCULAR DISORDERS